Review highlights Periostin (POSTN) as a promising biomarker and therapeutic target for diabetic kidney disease
Periostin in diabetic kidney disease: mechanistic insights, biomarkers, and therapeutic perspectives.
Abstract
Periostin (POSTN) drives renal inflammation and fibrosis in diabetic kidney disease (DKD), emerging as a promising novel biomarker and therapeutic target.
